BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4151337)

  • 1. [Atypical dose-frequency relation as characteristic of a beta receptor blocker].
    Klempt HW; Müller WD; Bender F
    Verh Dtsch Ges Inn Med; 1973; 79():1015-8. PubMed ID: 4151337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dose-response relationship of beta-adrenergic blocking agents].
    Seyberth H
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1663-5. PubMed ID: 4150008
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
    Cheymol G; Mouillé P; Schmitt H; Laubie M
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):45-51. PubMed ID: 4148408
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of beta receptor blockaders on pulse wave velocity. Studies of the new beta bockader Kö 1366].
    Klein K
    Wien Klin Wochenschr; 1973 Aug; 85(31):536-9. PubMed ID: 4147490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
    Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Kö 1366 on the distribution of intrarenal blood flow in normal canine kidneys.
    Nakamura M; Nose Y; Tomoike H; Shirai T; Kuroiwa A
    Arzneimittelforschung; 1974 Sep; 24(9):1325-8. PubMed ID: 4154766
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
    Regula H; Papner B
    Arzneimittelforschung; 1974 Sep; 24(9):1328-30. PubMed ID: 4154767
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 14. [Circulatory changes caused by a beta blocker. 1. Y-6124(Adobiol)].
    Shimamura K; Yoshida Y; Sakio H; Yasui A; Nakagawa K
    Masui; 1974 Oct; 23(11):1110-6. PubMed ID: 4155449
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electrical properties of a new beta-blocker agent, tertatolol, in man].
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Therapie; 1983; 38(4):371-8. PubMed ID: 6139893
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-sympatholytics as non-specific inhibitors of serum cholin-esterase.
    Hellenbrecht D; Müller KF
    Experientia; 1973 Oct; 29(10):1255-7. PubMed ID: 4148482
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris.
    Boakes AJ; Prichard BN
    Br J Pharmacol; 1973 Mar; 47(3):673P-674P. PubMed ID: 4147197
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenergic-induced vascular adjustments--initial and escape reactions. I. Influence of beta-adrenergic blocking agents on the intestinal circulation of the rat (in vivo).
    Henrich H; Singbartl G; Biester J
    Pflugers Arch; 1974 Jan; 346(1):1-12. PubMed ID: 4149759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.